Skip to main content
HR 4073 115th Congress House Crime and Law Enforcement Drug trafficking and controlled substances Licensing and registrations Prescription drugs Retail and wholesale trades

Opioid Immediate Suspension Order Act of 2017

Introduced: October 16, 2017 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Oct 20, 2017
Referred to the Subcommittee on Health.
Oct 16, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 16, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Opioid Immediate Suspension Order Act of 2017

This bill amends the Controlled Substances Act to eliminate the provision that defines the phrase "imminent danger to the public health and safety." Under current law, the Drug Enforcement Administration may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety.

What's happening now November 1, 2017

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Committees of jurisdiction 4